Clinical trial
Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema
NCT01520740 is registered in ClinicalTrials.gov with Aeris Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema
- Lead sponsor
- Aeris Therapeutics
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 29, 2012
- Completion date
- November 30, 2013
- Enrollment
- 100 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.